Trial intelligence / Profile preview

Tranexamic acid with or without dexamethasone for perioperative inflammation and fibrinolysis after total knee arthroplasty

ChiCTR1900026092Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tranexamic acid and dexamethasone in osteoarthritis (OA) and disorders of knee (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: C-reactive protein, Interleukin-6 and 7 more. Planned start Sep 2019; status: not yet recruiting.

02

Drugs

tranexamic aciddexamethasone
03

Conditions

osteoarthritis (OA)disorders of knee

Beyond the preview

Go deeper on ChiCTR1900026092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call